Wikipedia -WSS

Wikipedia

author：explore 2025-10-02 06:19:12 - browse：3932

Both Humana and CVS Health on Wednesday touted plans to aggressively scale their primary care clinics for seniors and funnel Medicare members into those clinics.

It’s a formula that’s been mastered by UnitedHealth Group, which is both the country’s largest Medicare Advantage insurer and one of the biggest physician employers. Even so, investors signaled they think Humana and CVS can catch up, sending both companies’ stock prices higher after their respective second quarter earnings calls Wednesday morning.

Both Humana and CVS, which owns the insurer Aetna, have made major leaps into primary care for older adults in recent years. Humana is partnering with a private equity firm to add more CenterWell Senior Primary Care sites, while CVS bought the Medicare provider Oak Street Health in May.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： Hearing on Medicare drug price negotiation gets unusually heated

hotspot

WSS

Senate HELP committee spars over health care workforce policies

Prosthetic arm enables patients to feel the objects they grip

Heat waves linked to early deliveries, preterm births in new study

Health insurers say they are turning to AI to cut costs, improve care

What Congress can do to address the rural doctor shortage

Why are Kaiser Permanente staff considering a strike?

leisure time

Wikipedia

entertainment

Affirmative action in medical school literally saved lives

Dark money group runs ads on China biotech bill

Novavax promises a turnaround & Lilly roils the obesity market

Childbirth

23andMe had bad news about my health. I wish a person had delivered it

Drug for rare kidney disease narrowly misses mark in clinical trial

Tori Bowie and the unacceptable rates of Black maternal death

Why are Kaiser Permanente staff considering a strike?

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Lab trade group sues FDA to halt regulation of lab

focus

Childbirth

Do more moles mean more problems? Not so, says new study

Insmed lung disease drug hits target in key Phase 3 trial

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

explore

hotspot

knowledge

focus